Zobrazeno 1 - 10
of 10
pro vyhledávání: '"K. Ivens"'
Autor:
Nashan B; Multi Organ Transplant Program, Dalhousie University, QE II Health Sciences Centre, Halifax, Nova Scotia B3H 2Y9, Canada., Suwelack B, Ivens K, Arns W, Lhotta K, Bourbigot B, Budde K, Fischer W, Pietruck F
Publikováno v:
Transplantation proceedings [Transplant Proc] 2006 Nov; Vol. 38 (9), pp. 2856-9.
Autor:
Heering PJ; Department of Medicine III, Solingen General Hospital, University of Cologne, Solingen, Germany. heering@klinikumsolingen.de, Kurschat C, Vo DT, Klein-Vehne N, Fehsel K, Ivens K
Publikováno v:
Clinical transplantation [Clin Transplant] 2004 Apr; Vol. 18 (2), pp. 186-92.
Autor:
Heering P; Klinik für Nephrologie und Rheumatologie, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany. heering@klinikumsolingen.de, Braun N, Müllejans R, Ivens K, Zäuner I, Fünfstück R, Keller F, Krämer BK, Schollmeyer P, Risler T, Grabensee B
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2004 Jan; Vol. 43 (1), pp. 10-8.
Autor:
Hörl MP; Department of Nephrology and Rheumatology, University of Düsseldorf, Düsseldorf, Germany., Schmitz M, Ivens K, Grabensee B
Publikováno v:
Current opinion in urology [Curr Opin Urol] 2002 Mar; Vol. 12 (2), pp. 115-23.
Autor:
Blume C; Medizinische Klinik und Poliklinik, Klinik für Nephrologie und Rheumatologie der Heinrich-Heine-Universität, Düsseldorf, Germany., Hollenbeck M, Ivens K, Heering P, Hetzel GR, Grabensee B
Publikováno v:
Transplantation proceedings [Transplant Proc] 2001 Nov-Dec; Vol. 33 (7-8), pp. 3161-3.
Autor:
Heering P; Klinik f. Nephrologie und Rheumatologie, Heinrich Heine University, Düsseldorf, Germany., Ivens K, Aker S, Grabensee B
Publikováno v:
Clinical transplantation [Clin Transplant] 1998 Oct; Vol. 12 (5), pp. 465-71.
Autor:
Flavin T; Department of Cardiovascular Surgery, Stanford University School of Medicine, California 94305-5247., Ivens K, Wang J, Gutierrez J, Hoyt EG, Billingham M, Morris RE
Publikováno v:
Transplantation proceedings [Transplant Proc] 1991 Feb; Vol. 23 (1 Pt 1), pp. 531-2.
Autor:
K. Lhotta, W. Arns, W H. Fischer, B. Suwelack, Klemens Budde, Bernard Bourbigot, B. Nashan, K. Ivens, F. Pietruck
Publikováno v:
Transplantation Proceedings. 38:2856-2859
Conversion from mycophenolate mofetil (MMF, CellCept) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) is safe and effective in renal transplant patients treated with the standard dose of 2 g MMF. In this 6-month, international, multicenter,
Publikováno v:
Clinical transplantation. 18(2)
After renal transplantation immunosuppressive drugs-like cyclosporin A (CsA) and FK506 induce either hypoaldosteronism or pseudo-hypoaldosteronism presenting with hyperkalemia and metabolic acidosis. We investigated the relationship between renal all
Publikováno v:
Transplantation proceedings. 23(1 Pt 1)